Gritstone Oncology Inc (GRTS)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart
Ticker: GRTS Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-20 2024-12-18 S Sale

Economides Vassiliki

EVP, CHIEF FINANCIAL OFFICER

Officer
12,000 -4.6%
0.02
USD 180 		12,000 -4.6% 0.02 USD 180
2024-05-17 2024-05-16 S Sale

Allen Andrew R

PRESIDENT AND CEO

Executive Director
24,263 -2.4%
0.75
USD 18,156 		24,263 -2.4% 0.75 USD 18,156
2024-05-17 2024-05-16 S Sale

Economides Vassiliki

EVP, CHIEF FINANCIAL OFFICER

Officer
13,749 -5.0%
0.75
USD 10,288 		13,749 -5.0% 0.75 USD 10,288
2024-05-17 2024-05-16 S Sale

Hawryluk Matthew

EVP, CHIEF BUSINESS OFFICER

Officer
9,259 -2.9%
0.75
USD 6,929 		9,259 -2.9% 0.75 USD 6,929
2024-05-17 2024-05-16 S Sale

Jooss Karin

SEE REMARKS

Officer
13,749 -2.0%
0.75
USD 10,288 		13,749 -2.0% 0.75 USD 10,288
2024-05-17 2024-05-16 S Sale

Jones Erin

EVP, CHIEF OPERATING OFFICER

Officer
13,749 -3.7%
0.75
USD 10,288 		13,749 -3.7% 0.75 USD 10,288
2023-05-24 2023-05-23 B Purchase

Economides Vassiliki

See Remarks

Officer
12,000 +5.9%
1.90
USD 22,829 		12,000 +5.9% 1.90 USD 22,829
2021-12-03 2021-12-01 PS Planned sale

Jones Erin

Chief Operating Officer

Officer
1,000 -2.1%
13.01
USD 13,010 		1,000 -2.1% 13.01 USD 13,010
2021-11-03 2021-11-01 PS Planned sale

Jones Erin

See Remarks

Officer
1,000 -4.8%
11.14
USD 11,140 		1,000 -4.8% 11.14 USD 11,140
2021-10-05 2021-10-04 PS Planned sale

Jones Erin

See Remarks

Officer
1,000 -4.8%
10.71
USD 10,710 		1,000 -4.8% 10.71 USD 10,710
2021-10-05 2021-10-01 PS Planned sale

Jones Erin

See Remarks

Officer
1,000 -4.8%
10.68
USD 10,680 		1,000 -4.8% 10.68 USD 10,680
2021-06-03 2021-05-27 S Sale

Rousseau Raphael

See Remarks

Officer
2,900 -100.0%
9.00
USD 26,112 		2,900 -100.0% 9.00 USD 26,112
2021-01-21 2021-01-20 PS Planned sale

Rousseau Raphael

See Remarks

Officer
10,000 -100.0%
25.07
USD 250,705 		10,000 -100.0% 25.07 USD 250,705
2021-01-21 2021-01-19 PS Planned sale

Rousseau Raphael

See Remarks

Officer
20,000 -100.0%
17.53
USD 350,564 		20,000 -100.0% 17.53 USD 350,564
2021-01-21 2021-01-19 S Sale

Yelensky Roman

See Remarks

Officer
10,000 -7.0%
22.10
USD 221,029 		10,000 -7.0% 22.10 USD 221,029
2021-01-04 2020-12-30 B Purchase

Woiwode Thomas

Non-Executive Director
1,347,709 +inf%
3.71
USD 5,000,000 		1,347,709 +inf% 3.71 USD 5,000,000
2019-08-23 2019-08-21 S Sale

Rousseau Raphael

See Remarks

Officer
10,000 -100.0%
10.76
USD 107,631 		10,000 -100.0% 10.76 USD 107,631
2018-10-02 2018-09-28 B Purchase

Simon Nicholas

Non-Executive Director Large shareholder
333,333 +inf%
15.00
USD 4,999,995 		333,333 +inf% 15.00 USD 4,999,995
2018-10-02 2018-09-28 B Purchase

Clarus Lifesciences III, L.P.

Large shareholder
333,333 +inf%
15.00
USD 4,999,995 		333,333 +inf% 15.00 USD 4,999,995
// ... existing code ... // ... rest of the file ...